|
1
|
Gardella S, Andrei C, Ferrera D, Lotti LV,
Torrisi MR, Bianchi ME and Rubartelli A: The nuclear protein HMGB1
is secreted by monocytes via a non-classical, vesicle-mediated
secretory pathway. EMBO Rep. 3:995–1001. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Fink MP: Bench-to-bedside review:
High-mobility group box 1 and critical illness. Crit Care.
11:2292007. View
Article : Google Scholar : PubMed/NCBI
|
|
3
|
Degryse B, Bonaldi T, Scaffidi P, Müller
S, Resnati M, Sanvito F, Arrigoni G and Bianchi ME: The high
mobility group (HMG) boxes of the nuclear protein HMG1 induce
chemotaxis and cytoskeleton reorganization in rat smooth muscle
cells. J Cell Biol. 152:1197–1206. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Palumbo R, Sampaolesi M, De Marchis F,
Tonlorenzi R, Colombetti S, Mondino A, Cossu G and Bianchi ME:
Extracellular HMGB1, a signal of tissue damage, induces
mesoangioblast migration and proliferation. J Cell Biol.
164:441–449. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Andersson U, Erlandsson-Harris H, Yang H
and Tracey KJ: HMGB1 as a DNA-binding cytokine. J Leukoc Biol.
72:1084–1091. 2002.PubMed/NCBI
|
|
6
|
Yang H, Wang H, Czura CJ and Tracey KJ:
HMGB1 as a cytokine and therapeutic target. J Endotoxin Res.
8:469–472. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Naglova H and Bucova M: HMGB1 and its
physiological and pathological roles. Bratisl Lek Listy.
113:163–171. 2012.PubMed/NCBI
|
|
8
|
Granero-Moltó F, Weis JA, Miga MI, Landis
B, Myers TJ, O'Rear L, Longobardi L, Jansen ED and Mortlock DP:
Regenerative effects of transplanted mesenchymal stem cells in
fracture healing. Stem Cells. 27:1887–1898. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Glass GE, Chan JK, Freidin A, Feldmann M,
Horwood NJ and Nanchahal J: TNF-alpha promotes fracture repair by
augmenting the recruitment and differentiation of muscle-derived
stromal cells. Proc Natl Acad Sci USA. 108:1585–1590. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Marsell R and Einhorn TA: The biology of
fracture healing. Injury. 42:551–555. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Mingari MC, Moretta A and Moretta L:
Regulation of KIR expression in human T cells: A safety mechanism
that may impair protective T-cell responses. Immunol Today.
19:153–157. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Guo Z, Yang J, Liu X, Li X, Hou C, Tang PH
and Mao N: Biological features of mesenchymal stem cells from human
bone marrow. Chin Med J (Engl). 114:950–953. 2001.PubMed/NCBI
|
|
13
|
Guo J, Jie W, Shen Z, Li M, Lan Y, Kong Y,
Guo S, Li T and Zheng S: SCF increases cardiac stem cell migration
through PI3K/AKT and MMP2/9 signaling. Int J Mol Med. 34:112–118.
2014.PubMed/NCBI
|
|
14
|
Sidney LE, Kirkham GR and Buttery LD:
Comparison of osteogenic differentiation of embryonic stem cells
and primary osteoblasts revealed by responses to IL-1β, TNF-α and
IFN-γ. Stem Cells Dev. 23:605–617. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Tso GH, Law HK, Tu W, Chan GC and Lau YL:
Phagocytosis of apoptotic cells modulates mesenchymal stem cells
osteogenic differentiation to enhance IL-17 and RANKL expression on
CD4+ T cells. Stem Cells. 28:939–954. 2010.PubMed/NCBI
|
|
16
|
Lda S Meirelles, Fontes AM, Covas DT and
Caplan AI: Mechanisms involved in the therapeutic properties of
mesenchymal stem cells. Cytokine Growth Factor Rev. 20:419–427.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Yuk JM, Yang CS, Shin DM, Kim KK, Lee SK,
Song YJ, Lee HM, Cho CH, Jeon BH and Jo EK: A dual regulatory role
of apurinic/apyrimidinic endonuclease 1/redox factor-1 in
HMGB1-induced inflammatory responses. Antioxid Redox Signal.
11:575–588. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Lee W, Ku SK, Bae JW and Bae JS:
Inhibitory effects of lycopene on HMGB1-mediated pro-inflammatory
responses in both cellular and animal models. Food Chem Toxicol.
50:1826–1833. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Meng E, Guo Z, Wang H, Jin J, Wang J, Wang
H, Wu C and Wang L: High mobility group box 1 protein inhibits the
proliferation of human mesenchymal stem cells and promotes their
migration and differentiation along osteoblastic pathway. Stem
Cells Dev. 17:805–813. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2−ΔΔCt method. Methods. 25:402–408. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Nonomura A, Ohta G, Nakanuma Y, Izumi R,
Mizukami Y, Matsubara F, Hayashi M, Watanabe K and Takayanagi N:
Simultaneous detection of epidermal growth factor receptor (EGF-R),
epidermal growth factor (EGF) and ras p21 in cholangiocarcinoma by
an immunocytochemical method. Liver. 8:157–166. 1988. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Zlotnik A and Yoshie O: Chemokines: A new
classification system and their role in immunity. Immunity.
12:121–127. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Pham K, Luo D, Liu C and Harrison JK:
CCL5, CCR1 and CCR5 in murine glioblastoma: Immune cell
infiltration and survival rates are not dependent on individual
expression of either CCR1 or CCR5. J Neuroimmunol. 246:10–17. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Lee JK, Schuchman EH, Jin HK and Bae JS:
Soluble CCL5 derived from bone marrow-derived mesenchymal stem
cells and activated by amyloid β ameliorates Alzheimer's disease in
mice by recruiting bone marrow-induced microglia immune responses.
Stem Cells. 30:1544–1555. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Errahali YJ, Taka E, Abonyo BO and Heiman
AS: CCL26-targeted siRNA treatment of alveolar type II cells
decreases expression of CCR3-binding chemokines and reduces
eosinophil migration: Implications in asthma therapy. J Interferon
Cytokine Res. 29:227–239. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
De Vries TJ, Schoenmaker T, Aerts D,
Grevers LC, Souza PP, Nazmi K, van de Wiel M, Ylstra B, Lent PL,
Leenen PJ and Everts V: M-CSF priming of osteoclast precursors can
cause osteoclastogenesis-insensitivity, which can be prevented and
overcome on bone. J Cell Physiol. 230:210–225. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Karst M, Gorny G, Galvin RJ and Oursler
MJ: Roles of stromal cell RANKL, OPG and M-CSF expression in
biphasic TGF-beta regulation of osteoclast differentiation. J Cell
Physiol. 200:99–106. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Kazemi-Lomedasht F, Behdani M, Bagheri KP,
Habibi-Anbouhi M, Abolhassani M, Arezumand R, Shahbazzadeh D and
Mirzahoseini H: Inhibition of angiogenesis in human endothelial
cell using VEGF specific nanobody. Mol Immunol. 65:58–67. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Henriksen K, Karsdal M, Delaisse JM and
Engsig MT: RANKL and vascular endothelial growth factor (VEGF)
induce osteoclast chemotaxis through an ERK1/2-dependent mechanism.
J Biol Chem. 278:48745–48753. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Kayal RA, Tsatsas D, Bauer MA, Allen B,
Al-Sebaei MO, Kakar S, Leone CW, Morgan EF, Gerstenfeld LC, Einhorn
TA and Graves DT: Diminished bone formation during diabetic
fracture healing is related to the premature resorption of
cartilage associated with increased osteoclast activity. J Bone
Miner Res. 22:560–568. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Lee K, Kim H, Kim JM, Kim JR, Kim KJ, Kim
YJ, Park SI, Jeong JH, Moon YM, Lim HS, et al: Systemic
transplantation of human adipose-derived stem cells stimulates bone
repair by promoting osteoblast and osteoclast function. J Cell Mol
Med. 15:2082–2094. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Wang CL, Jiang H and Sun JB: EGF and SCF
promote the proliferation and differentiation of mouse
spermatogenic cells in vitro. Zhonghua Nan Ke Xue. 20:679–683.
2014.(In Chinese). PubMed/NCBI
|
|
33
|
Kikuchi A, Amagai M, Hayakawa K, Ueda M,
Hirohashi S, Shimizu N and Nishikawa T: Association of EGF receptor
expression with proliferating cells and of ras p21 expression with
differentiating cells in various skin tumours. Br J Dermatol.
123:49–58. 1990. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Scholz ME, Meissner JD, Scheibe RJ, Umeda
PK, Chang KC, Gros G and Kubis HP: Different roles of H-ras for
regulation of myosin heavy chain promoters in satellite
cell-derived muscle cell culture during proliferation and
differentiation. Am J Physiol Cell Physiol. 297:C1012–C1018. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Peng S, Zhou G, Luk KD, Cheung KM, Li Z,
Lam WM, Zhou Z and Lu WW: Strontium promotes osteogenic
differentiation of mesenchymal stem cells through the Ras/MAPK
signaling pathway. Cell Physiol Biochem. 23:165–174. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Yao B, Zhang Y, Delikat S, Mathias S, Basu
S and Kolesnick R: Phosphorylation of Raf by ceramide-activated
protein kinase. Nature. 378:307–310. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Mor A and Philips MR: Compartmentalized
Ras/MAPK signaling. Annu Rev Immunol. 24:771–800. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Zeiller C, Blanchard MP, Pertuit M,
Thirion S, Enjalbert A, Barlier A and Gerard C: Ras and Rap1 govern
spatiotemporal dynamic of activated ERK in pituitary living cells.
Cell Signal. 24:2237–2248. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Hubbard PA, Moody CL and Murali R:
Allosteric modulation of Ras and the PI3K/AKT/mTOR pathway:
Emerging therapeutic opportunities. Front Physiol. 5:4782014.
View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Binger T, Stich S, Andreas K, Kaps C,
Sezer O, Notter M, Sittinger M and Ringe J: Migration potential and
gene expression profile of human mesenchymal stem cells induced by
CCL25. Exp Cell Res. 315:1468–1479. 2009. View Article : Google Scholar : PubMed/NCBI
|
